Učitavanje...
Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
PURPOSE: Nausea and vomiting are major adverse effects of chemotherapy and can greatly impact patients’ quality of life. Although chemotherapy-induced nausea and vomiting (CINV) prevalence is high, treatment remains difficult. Palonosetron is a 5-hydroxytryptamine receptor antagonist (5-HT(3)RA) app...
Spremljeno u:
| Izdano u: | Ther Clin Risk Manag |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435088/ https://ncbi.nlm.nih.gov/pubmed/25999723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S68130 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|